Distinct Roles for Nigral GABA and Glutamate Receptors in the Regulation of Dendritic Dopamine Release under Normal Conditions and in Response to Systemic Haloperidol
- 15 February 2002
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 22 (4) , 1407-1413
- https://doi.org/10.1523/JNEUROSCI.22-04-01407.2002
Abstract
The regulation of dendritic dopamine release in the substantia nigra (SN) likely involves multiple mechanisms. GABA and glutamate inputs to nigrostriatal dopamine neurons exert powerful influences on dopamine neuron physiology; therefore, it is probable that GABA and glutamate likewise influence dendritic dopamine release, at least under some conditions. The present studies used in vivomicrodialysis to determine the potential roles of nigral GABA and glutamate receptors in the regulation of dendritic dopamine release under normal conditions and when dopamine signaling in the basal ganglia is compromised after systemic haloperidol administration. Nigral application of the GABAA receptor antagonist bicuculline by reverse dialysis significantly increased spontaneous dopamine efflux in the SN. However, spontaneous dopamine efflux in the SN was not significantly affected by local application of the glutamate receptor antagonists 6-cyano-7-nitroquinoxaline-2,3-dione or (±)-3-[2-carboxypiperazine-4-yl]-propyl-1-phosphonic acid. Systemic haloperidol administration significantly increased the extracellular dopamine measured in the SN. Blockade of nigral GABAA receptors by local bicuculline application did not alter this effect of systemic haloperidol, despite the bicuculline-induced increase in spontaneous dendritic dopamine efflux. In contrast, nigral application of either glutamate receptor antagonist significantly attenuated the increases in dendritic dopamine efflux elicited by systemic haloperidol. These data suggest that under normal conditions, activity of GABA afferents to SN dopamine neurons is an important determinant of the spontaneous level of dendritic dopamine release. Circuit-level changes in the basal ganglia involving an increased glutamatergic drive to the SN appear to underlie the increase in dendritic dopamine release that occurs in response to systemic haloperidol administration.Keywords
This publication has 65 references indexed in Scilit:
- The Regulation of Motor Control: An Evaluation of the Role of Dopamine Receptors in the Substantia NigraReviews in the Neurosciences, 1997
- Biochemistry of Somatodendritic Dopamine Release in Substantia Nigra: An In Vivo Comparison with Striatal Dopamine ReleaseJournal of Neurochemistry, 1995
- Acute monoaminergic depletion in the rat potentiates the excitatory effect of the subthalamic nucleus in the substantia nigra pars reticulata but not in the pallidal complexJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1991
- Kynurenate blocks the acute effects of haloperidol on midbrain dopamine neurons recorded in vivoJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1991
- Modulation of Dendritic Release of Dopamine by N‐Methyl‐D‐Aspartate Receptors in Rat Substantia NigraJournal of Neurochemistry, 1989
- Evidence that the substantia nigra is a site of action for l-DOPANeuroscience Letters, 1988
- Neuronal responses to iontophoretically applied dopamine, glutamate, and GABA of identified dopaminergic cells in the rat substantia nigra after kainic acid-induced destruction of the striatumExperimental Brain Research, 1982
- High correlations between number of dopamine cells, dopamine levels and motor performanceBrain Research, 1977
- Amphetamine-induced release of dopamine from the substantia nigraLife Sciences, 1976
- Release of dopamine from dendrites in rat substantia nigraNature, 1976